Evidence map›Paper›PMID 31770003›Full record

GuidelineAnnals of the American Thoracic Society2020

Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia. A Technical Paper on Standardized Testing Protocols.

Adam J Shapiro, Sharon D Dell, Benjamin Gaston, Michael O'Connor, Nadzeya Marozkina, Michele Manion, Milan J Hazucha, Margaret W Leigh

2 registry-linked trialsOpen access · greenAbstract readPractice Guideline
In one paragraph

Guideline in Annals of the American Thoracic Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05287022 recruitingnot on this mapstarted 2021, after this paper: background citation

Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

TypeobservationalSponsorArkansas Children's Hospital Research InstituteRan2021 to 2030Enrolled150ConditionsPrimary Ciliary Dyskinesia
NCT06959251 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Randomized, Placebo-controlled Clinical Trial Evaluating the Efficacy and Safety of Glycine and Magnesium+Thiamine Supplements, Alone or Combined, Administered for 6 Months to Patients With Primary Ciliary Dyskinesia

TypeinterventionalSponsorInstituto Nacional de Enfermedades RespiratoriasRan2025 to 2028Enrolled60ConditionsPrimary Ciliary DyskinesiaArmsGlycine, Magnesium+thiamine, Placebo
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Unrecognized ciliary motility disorders in neutrophilic severe asthma exacerbations.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Case report: novelFrontiers in genetics · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 2 countries.

Adam J ShapiroDivision of Pediatric Respiratory Medicine, McGill University Health Centre Research Institute, Montreal Children's Hospital, Montreal, Quebec, Canada.ORCID 0000-0001-6066-6750
Sharon D DellDivision of Respiratory Medicine, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-2169-9407
Benjamin GastonChildren's Lung Foundation Professor of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, Ohio.
Michael O'ConnorDivision of Pediatric Pulmonary, Allergy, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Nadzeya MarozkinaDepartment of Pediatrics, Case Western Reserve University, Cleveland, Ohio.
Michele ManionPCD Foundation, Minneapolis, Minnesota.
Milan J HazuchaDepartment of Medicine.
Margaret W LeighDepartment of Pediatrics, and.
Case Western Reserve University · USCenter for Environmental Health · USMinneapolis Foundation · USMontreal Children's Hospital · CARainbow Babies & Children's Hospital · USUniversity of North Carolina at Chapel Hill · USUniversity of Toronto · CAVanderbilt University Medical Center · US

Funding

Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary DyskinesiaU54HL096458 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVIS, STEPHANIE DUGGINS, FERKOL, THOMAS W · 2009 to 2023
$20.0M
UNC Clinical and Translational Science AwardUL1TR000083 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2012 to 2013
$11.6M
NCATS NIH HHS UL1 TR000083NHLBI NIH HHS U54 HL096458
6 · The paper itself

Abstract

Nasal nitric oxide concentrations are extremely low in primary ciliary dyskinesia (PCD), and measurement of this nasal gas is recommended as a PCD diagnostic test in cooperative patients aged 5 years and older. However, nasal nitric oxide measurements must be performed with chemiluminescence analyzers using a standardized protocol to ensure proper results, because nasal nitric oxide values can be influenced by various internal and external factors. Repeat nasal nitric oxide testing on separate visits is required to ensure that low diagnostic values are persistent and consistent with PCD. This technical paper presents the standard operating procedures for nasal nitric oxide measurement used by the PCD Foundation Clinical and Research Centers Network at various specialty centers across North America. Adherence to this document ensures reliable nasal nitric oxide testing and high diagnostic accuracy when employed in a population with appropriate clinical phenotypes for PCD.

Indexed as

Breath TestsHumansKartagener SyndromeNasal CavityNitric OxidePatient SelectionSensitivity and SpecificitySocieties, MedicalUnited StatesNitric OxideKartagener syndromenasal nitric oxideprimary ciliary dyskinesia

Identifiers

PMID31770003
PMCPMC6993796
OpenAlexW2990681887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.